Singapore markets closed

PROCEPT BioRobotics Corporation (PRCT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
48.84+2.41 (+5.19%)
At close: 04:00PM EDT
48.78 -0.06 (-0.12%)
After hours: 06:05PM EDT

PROCEPT BioRobotics Corporation

150 Baytech Drive
San Jose, CA 95134
United States
650 232 7200
https://www.procept-biorobotics.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees626

Key executives

NameTitlePayExercisedYear born
Dr. Reza Zadno Ph.D.President, CEO & Director1.26MN/A1955
Mr. Kevin WatersExecutive VP & CFO744.1kN/A1977
Ms. Alaleh NouriEVP, Chief Legal Officer & Corporate Secretary713.61kN/A1979
Mr. Hisham ShiblaqExecutive VP & Chief Commercial Officer757.2kN/A1976
Mr. Mohan F. SanchetiSenior Vice President of OperationsN/AN/A1964
Mr. Barry TemplinExecutive VP of Technology & Clinical DevelopmentN/AN/AN/A
Mr. Matthew James Bacso C.F.A.Vice President of Investor RelationsN/AN/AN/A
Ms. Stacey L. PorterChief People OfficerN/AN/A1976
Mr. Bijesh ChandranSenior Vice President of Regulatory Affairs & Quality AssuranceN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Corporate governance

PROCEPT BioRobotics Corporation’s ISS governance QualityScore as of 1 March 2024 is 6. The pillar scores are Audit: 5; Board: 4; Shareholder rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.